APOL1 and cancer: One such example, APOL1 displays copy number loss in 73.8% of ovarian cancers and 33.5% of tumors of the large intestine, but is not subject to genetic inactivation in liver cancer, based on the Catalogue of Somatic Mutations in Cancer (COSMIC, [46]).